Perrigo Rogaine Foam ANDA May Help Extend Record Growth
This article was originally published in The Tan Sheet
Perrigo's regulatory green light to market the first OTC generic of Men's Rogaine Foam further extends the pipeline that has kept the firm on a streak of record earnings.
You may also be interested in...
Private label giant Perrigo is readying generic competitors to Reckitt Benckiser’s Mucinex and Takeda Pharmaceuticals’ Prevacid, CEO Joseph Papa says.
Perrigo will launch private-label equivalents of OTC heartburn reliever Zantac 150 this summer.
FDA proposes laxative monograph change